홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

4-Methylmorpholine → HCID 178445920, 화합물

HRID 464905
인쇄

반응식

HRID 464905 반응식
[CH2:1]([O:8][C:9]([NH:11][C@H:12](C(O)=O)[CH2:13][C:14]1[C:23]2[C:18](=[CH:19][CH:20]=[CH:21][CH:22]=2)[CH:17]=[CH:16][CH:15]=1)=[O:10])C1C=CC=CC=1.ON1C(=O)[CH:36]2[CH:31]([CH:32]3C[CH:35]2[CH:34]=[CH:33]3)C1=O.ClC(Cl)CCCCCN=C=N.Br.Br.[C:53]1([CH2:63][C@@H:64]([C:66]([NH:68][C@H:69]([C:76]([NH:78][C@H:79]([CH2:84][OH:85])[CH2:80][CH:81]([CH3:83])[CH3:82])=[O:77])[CH2:70][C:71]2[N:75]=[CH:74][NH:73][CH:72]=2)=[O:67])[NH2:65])[C:62]2[C:57](=[CH:58][CH:59]=[CH:60][CH:61]=2)[CH:56]=[CH:55][CH:54]=1.CN1CC[O:90][CH2:89]C1>CN(C)C=O.C(Cl)Cl>[CH2:1]([O:8][C:9]([NH:11][C@H:12]([C:89]([N:68]([C:66](=[O:67])[C@H:64]([CH2:63][C:53]1[C:62]2[C:57](=[CH:58][CH:59]=[CH:60][CH:61]=2)[CH:56]=[CH:55][CH:54]=1)[NH2:65])[C@H:69]([C:76]([NH:78][C@H:79]([CH2:84][OH:85])[CH2:80][CH:81]([CH3:82])[CH3:83])=[O:77])[CH2:70][C:71]1[N:75]=[CH:74][NH:73][CH:72]=1)=[O:90])[CH2:13][C:14]1[C:19]2[C:18](=[CH:23][CH:22]=[CH:21][CH:20]=2)[CH:17]=[CH:16][CH:15]=1)=[O:10])[C:31]1[CH:36]=[CH:35][CH:34]=[CH:33][CH:32]=1
참가 물질반응 조건실험 절차후처리출처 및 근거반응 노트

참가 물질

8

반응물 5

HCID 79724-MethylmorpholineHCID 895293a,4,7,7a-Tetrahydro-2-hydroxy-4,7-methano-1H-isoindole-1,3(2H)-dioneHCID 7020250Z-1-Nal-OHHCID 71510291DichlorohexylcarbodiimideHCID 178419252HCID 178419252, 화합물

생성물 1

HCID 178445920HCID 178445920, 화합물

시약·촉매·용매 2

HCID 6228Dimethylformamide용매HCID 6344Dichloromethane용매

반응 조건

온도
0 °C

실험 절차

70 mg. (0.2 mmole) of N-benzyloxycarbonyl-3-(1-naphthyl)-L-alanine and 40 mg. (0.22 mmole) of N-hydroxy-5-norbornene-2,3-dicarboximide were dissolved in 2 ml. of methylene chloride. The solution was cooled to 0° C., and there were then added 50 mg. (0.24 mmole) of dichlorohexylcarbodiimide; the mixture was stirred at 0° C. for 1 hour. The resulting solution was added to a cooled solution prepared from 5 ml. of a dimethylformamide solution of 123 mg. (0.2 ml.) of 3-(1-naphthyl)-L-alanyl-L-histidyl-L-leucinol dihydrobromide by neutralization with 20 mg. (0.2 mmole) of N-methylmorpholine. The mixture was stirred overnight at room temperature. The dicyclohexylurea precipitated was removed by filtration, and the filtrate was concentrated by evaporation under reduced pressure. To the residue was added a 5% w/v aqueous solution of sodium bicarbonate, and the oily substance thus formed was extracted with ethyl acetate. The organic layer was washed successively with water and with a saturated aqueous solution of sodium chloride, dried over anhydrous sodium sulphate and concentrated by evaporation under reduced pressure. When a small amount of water was added to the residual syrup, it solidified and was separated by filtration. This product (143 mg) was then purified by silica gel column chromatography (eluent: chloroform/methanol 10:1 by volume) to afford 55 mg. of the desired compound as a white powdery solid, melting at 199°-200° C.; [α]24 -81.6° (C=0.5, methanol).

후처리

  1. additionthere were then added 50 mg
  2. additionThe resulting solution was added to a cooled solution
  3. customprepared from 5 ml
  4. stirringThe mixture was stirred overnight at room temperature
  5. customThe dicyclohexylurea precipitated
  6. customwas removed by filtration
  7. concentrationthe filtrate was concentrated by evaporation under reduced pressure
  8. additionTo the residue was added a 5% w/v aqueous solution of sodium bicarbonate
  9. customthe oily substance thus formed
  10. extractionwas extracted with ethyl acetate
  11. washThe organic layer was washed successively with water and with a saturated aqueous solution of sodium chloride
  12. dry with materialdried over anhydrous sodium sulphate
  13. concentrationconcentrated by evaporation under reduced pressure
  14. additionWhen a small amount of water was added to the residual syrup, it
  15. customwas separated by filtration
  16. customThis product (143 mg) was then purified by silica gel column chromatography (eluent: chloroform/methanol 10:1 by volume)
  17. customto afford 55 mg

출처 및 근거

ORD 기록
ord-fbd3c44111994d06bf127e1c8baa3ccd
출처 데이터셋
uspto-grants-1985_10
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US04548926

반응 노트

이 페이지에서참가 물질반응 조건실험 절차후처리출처 및 근거반응 노트